References
- Chen G, Zhang X, Yang F, Mu L. (2010). Disposition of nanoparticle-based delivery system via inner ear administration. Curr Drug Metab 11:886–97
- Discher BM, Won YY, Ege DS, et al. (1999). Polymersomes: tough vesicles made from diblock copolymers. Science 284:1143–6
- Gelperina S, Kisich K, Iseman MD, Heifets L. (2005). The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 172:1487–90
- Goycoolea MV. (2001). Clinical aspects of round window membrane permeability under normal and pathological conditions. Acta Otolaryngol 121:437–47
- Guzman LA, Labhasetwar V, Song C, et al. (1996). Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty. Circulation 94:1441–8
- Juhn SK, Rybak LP, Fowlks WL. (1982). Transport characteristics of the blood–perilymph barrier. Am J Otolaryngol 3:392–6
- Kang H, Kim JD, Han SH, Chang IS. (2002). Self-aggregates of poly(2-hydroxyethyl aspartamide) copolymers loaded with methotrexate by physical and chemical entrapments. J Control Release 81:135–44
- McCall AA, Swan EE, Borenstein JT, et al. (2010). Drug delivery for treatment of inner ear disease: current state of knowledge. Ear Hear 31:156–65
- Moss OR, Wong VA. (2006). When nanoparticles get in the way: impact of projected area on in vivo and in vitro macrophage function. Inhal Toxicol 18:711–16
- Park SN, Back SA, Choung YH, et al. (2011). alpha-Synuclein deficiency and efferent nerve degeneration in the mouse cochlea: a possible cause of early-onset presbycusis. Neurosci Res 71:303–10
- Parnes LS, Sun AH, Freeman DJ. (1999). Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 109:1–17
- Pyykko I, Zou J, Zhang W, Zhang Y. (2011). Nanoparticle-based delivery for the treatment of inner ear disorders. Curr Opin Otolaryngol Head Neck Surg 19:388–96
- Rask-Andersen H, Schrott-Fischer A, Pfaller K, Glueckert R. (2006). Perilymph/modiolar communication routes in the human cochlea. Ear Hear 27:457–65
- Roy S, Johnston AH, Newman TA, et al. (2010). Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-derived peptide ligand: potential tool for drug delivery. Int J Pharm 390:214–24
- Sajjadi H, Paparella MM. (2008). Meniere’s disease. Lancet 372:406–14
- Salt AN, King EB, Hartsock JJ, et al. (2012). Marker entry into vestibular perilymph via the stapes following applications to the round window niche of guinea pigs. Hear Res 283:14–23
- Slattery WH, Fisher LM, Iqbal Z, et al. (2005). Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg 133:251–9
- Surovtseva EV, Johnston AH, Zhang W, et al. (2012). Prestin binding peptides as ligands for targeted polymersome mediated drug delivery to outer hair cells in the inner ear. Int J Pharm 424:121–7
- Yang SR, Kim SB, Joe CO, Kim JD. (2008). Intracellular delivery enhancement of poly(amino acid) drug carriers by oligoarginine conjugation. J Biomed Mater Res A 86:137–48
- Yokoyama M, Miyauchi M, Yamada N, et al. (1990). Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res 50:1693–700
- Zhang Y, Zhang W, Johnston AH, et al. (2010). Improving the visualization of fluorescently tagged nanoparticles and fluorophore-labeled molecular probes by treatment with CuSO(4) to quench autofluorescence in the rat inner ear. Hear Res 269:1–11
- Zhang Y, Zhang W, Lobler M, et al. (2011). Inner ear biocompatibility of lipid nanocapsules after round window membrane application. Int J Pharm 404:211–19
- Zou J, Sood R, Ranjan S, et al. (2010). Manufacturing and in vivo inner ear visualization of MRI traceable liposome nanoparticles encapsulating gadolinium. J Nanobiotechnol 8:32